Adipiplon
Adipiplon is a nonbenzodiazepine hypnotic drug that was developed for the treatment of insomnia. It functions as a GABAA receptor agonist, specifically targeting the α3 subunit of the receptor. Adipiplon was designed to provide the sedative effects necessary for sleep induction and maintenance without the side effects commonly associated with benzodiazepines.
Mechanism of Action[edit | edit source]
Adipiplon works by binding to the GABAA receptor, which is a type of ligand-gated ion channel in the central nervous system. By enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at this receptor, adipiplon increases chloride ion influx into neurons, leading to hyperpolarization and decreased neuronal excitability. This results in a sedative effect, making it easier for individuals to fall asleep and stay asleep.
Pharmacokinetics[edit | edit source]
The pharmacokinetics of adipiplon involve its absorption, distribution, metabolism, and excretion. After oral administration, adipiplon is rapidly absorbed into the bloodstream. It is metabolized primarily in the liver by the cytochrome P450 enzyme system, particularly CYP3A4. The metabolites are then excreted via the kidneys.
Clinical Trials[edit | edit source]
Adipiplon has undergone several clinical trials to evaluate its efficacy and safety in treating insomnia. These trials have shown that adipiplon is effective in reducing the time to sleep onset and increasing total sleep time. However, some trials have also reported side effects such as dizziness, headache, and nausea.
Side Effects[edit | edit source]
Common side effects of adipiplon include:
Less common but more severe side effects may include:
Regulatory Status[edit | edit source]
As of the latest updates, adipiplon has not been approved by major regulatory agencies such as the Food and Drug Administration (FDA) for clinical use. Further studies are required to fully establish its safety profile and therapeutic efficacy.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
